Generic Name:
risdiplam
Project Status:
Active
Therapeutic Area:
Spinal muscular atrophy
Manufacturer:
Hoffmann La-Roche Ltd.
Brand Name:
Evrysdi
Project Line:
Reimbursement Review
Project Number:
SR0661-000
NOC Status at Filing:
Pre NOC
Details
Manufacturer Requested Reimbursement Criteria1:
For the treatment of spinal muscular atrophy (SMA) in patients 2 months and older.
Submission Type:
Initial
Fee Schedule:
Schedule A
Indications:
For the treatment of spinal muscular atrophy (SMA) in patients 2 months and older.
Recommendation Type:
Reimburse with clinical criteria and/or conditions
Final Recommendation:
- The requested reimbursement criteria are provided by the applicant and do not necessarily reflect the views of CADTH. Reimbursement criteria from CADTH will be documented in the final recommendation, if applicable.